Reducing stigma for Tajik migrants who use drugs in Russia
Official title: Intersectional Stigma Reduction for Tajik Migrants Who Inject Drugs
Funded at University of Illinois at Chicago · NIH-11064832 · Data updated 2026-11-12
This study looks at how Tajik migrants who use drugs in Russia deal with stigma and how it impacts their health and access to HIV prevention and treatment, aiming to find ways to help them get better care and support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | August 4, 2023 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $165,236 |
| NIH project number | 5R01TW012665-03 |
| Project ID | NIH-11064832 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Tajik migrants living in Russia who inject drugs and are at risk for HIV.
✕Less likely to help
Patients who do not inject drugs or are not part of the Tajik migrant community may not benefit from this research.
What this research studies
This research investigates the stigma faced by Tajik migrants who inject drugs while living in Russia, focusing on how this stigma affects their health and access to HIV prevention and treatment services. The study aims to understand the unique challenges these individuals face due to their intersecting identities as migrants and drug users, which can lead to increased HIV risk behaviors and poorer health outcomes. By exploring the social dynamics within the Tajik diaspora in Moscow, the research seeks to identify effective strategies for reducing stigma and improving health services for this vulnerable population.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and access to HIV prevention and treatment services for Tajik migrants who inject drugs.
How similar studies have gone: Previous research has shown that addressing stigma can significantly improve health outcomes for marginalized populations, suggesting that this approach may be effective.
Where this research is happening
-
University of Illinois at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Mackesy-Amiti, Mary Ellen — University of Illinois at Chicago
- Study coordinator: Mackesy-Amiti, Mary Ellen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.